Hypericin and its Derivatives Act as Radiosensitizing Agents That Can Inhibit Tumor Initiating Cell Viability

Publisher： Bentham Science Publishers

ISSN： 2212-697X

Source： Clinical Cancer Drugs, Vol.2, Iss.2, 2015-10, pp. : 119-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Porphyrins as Radiosensitizing Agents for Solid Neoplasms

By  

Current Pharmaceutical Design, Vol. 9, Iss. 25, 2003-10 ,pp. : 2024-2035

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Initiating Cells

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 192-196

Bentham Science Publishers

Access to resources Recommend Favorite

Model‐Based Evaluation of Radiation and Radiosensitizing Agents in Oncology

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 7, Iss. 1, 2018-01 ,pp. : 51-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor

By Hsu Lih-Ching  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1379-1388

Springer Publishing Company

Access to resources Recommend Favorite

Inducible Nitric Oxide Synthase-Vascular Endothelial Growth Factor Axis: A Potential Target to Inhibit Tumor Angiogenesis by Dietary Agents

By  

Current Cancer Drug Targets, Vol. 7, Iss. 5, 2007-08 ,pp. : 475-483

Bentham Science Publishers

Access to resources Recommend Favorite